ROYAL PHARMACEUTICALS

Serial Number 87112891
Registration 5387582
702

Registration Progress

Application Filed
Jul 22, 2016
Under Examination
Sep 5, 2017
Approved for Publication
Jul 11, 2017
Published for Opposition
Jul 11, 2017
Registered
Jan 23, 2018

Trademark Image

ROYAL PHARMACEUTICALS

Basic Information

Serial Number
87112891
Registration Number
5387582
Filing Date
July 22, 2016
Registration Date
January 23, 2018
Published for Opposition
July 11, 2017
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Feb 22, 2025
Registration
Registered
Classes
035

Rights Holder

Royal Pharmaceuticals, LLC

16
Address
21967 Highway 34 - Building C, Suite 103
Atlantic Corporate Center
Wall, NJ 07719

Ownership History

Royal Pharmaceuticals, LLC

Original Applicant
16
Manasquan, NJ

Royal Pharmaceuticals, LLC

Owner at Publication
16
Manasquan, NJ

Royal Pharmaceuticals, LLC

Original Registrant
16
Wall, NJ

Legal Representation

Attorney
Gregory F. Kotchick

USPTO Deadlines

Next Deadline
719 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20180123)
Due Date
January 23, 2028
Grace Period Ends
July 23, 2028

Application History

30 events
Date Code Type Description Documents
Feb 22, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Feb 22, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Feb 4, 2025 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
Aug 7, 2024 PR23 O POST REGISTRATION ACTION MAILED - SEC. 8 & 15 Loading...
Aug 3, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 18, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jan 23, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jan 23, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 19, 2017 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 18, 2017 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 13, 2017 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 30, 2017 IUAF S USE AMENDMENT FILED Loading...
Dec 13, 2017 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 30, 2017 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 5, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 11, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 11, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 21, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 6, 2017 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 3, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 2, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 2, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 26, 2017 ALIE A ASSIGNED TO LIE Loading...
May 4, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 9, 2016 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 9, 2016 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 9, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 9, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 2, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 28, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 035
Distributorships and wholesale distributorships and retail store services featuring branded FDA approved and unapproved pharmaceutical products and vitamins for sale to national distributors, wholesalers, retail chains and health systems
First Use Anywhere: Aug 1, 2008
First Use in Commerce: Aug 1, 2008

Classification

International Classes
035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"